Bengaluru: Axis Bank to set up paediatrics wing at IISC's Bagchi Parthasarathy Hospital
The Axis Bank Pediatrics Wing will be equipped with the latest technology in neonatal care and will have twenty state-of-the-art Neonatal ICU (NICU) beds for the care of critically-ill neonates.
Bengaluru: A Memorandum of Understanding (MoU) was recently signed between Axis Bank, India's third largest sector bank, and the Indian Institute of Science (IISc), Bengaluru, to set up a Pediatrics Wing at IISc's new Bagchi-Parthasarathy Hospital.
The Axis Bank Pediatrics Wing will be equipped with the latest technology in neonatal care and will have twenty state-of-the-art Neonatal ICU (NICU) beds for the care of critically-ill neonates. The dedicated wing will also enable postgraduate students to undergo world-class training in pediatrics care and further contribute to the development of innovative solutions in this field. This will take forward the IISc Medical School's ethos of creating a generation of physician-scientists capable of melding clinical care with cutting-edge research.
The Axis Bank Pediatrics Wing is expected to be operational by early 2025.
Also read- IISc's Upcoming Bagchi-Parthasarathy Hospital To Get Geriatrics Wing
Commenting on the occasion, Prof Govindan Rangarajan, Director, IISc, said, "We thank Axis Bank for partnering with us in our quest to push the frontiers of clinical research through the establishment of the Axis Bank Pediatrics Wing. Innovation in neonatal and pediatric care is the need of the hour in a fast-developing country like India. Axis Bank's support of the pediatrics wing at IISc will contribute to securing the health of our country's future generations."
Mr. Subrat Mohanty, Group Executive, Axis Bank, said, "We are proud to partner with the Indian Institute of Science (IISc), India's premier research institution, for the Pediatrics Wing at the Bagchi-Parthasarathy Hospital. Our aim is to achieve excellence in clinical research in pediatrics and neonatal care, which is critical for India. We hope this collaboration serves our community and the nation for a long time."
IISc Director, Prof Govindan Rangarajan, said, "Innovation in neonatal and pediatric care is the need of the hour in a fast-developing country like India. Axis Bank's support of the pediatrics wing at IISc will contribute to securing the health of our country's future generations."
Group Executive, Axis Bank, Subrat Mohanty, told PTI, "Our aim is to achieve excellence in clinical research in the field of pediatrics and neonatal care that is critical for India."
IISc was established in 1909 by a visionary partnership between the industrialist Jamsetji Nusserwanji Tata, the Mysore royal family, and the Government of India.
Over the last 111 years, IISc has become India's premier institute for advanced scientific and technological research and education. Its mandate is "to provide for advanced instruction and to conduct original investigations in all branches of knowledge as are likely to promote the material and industrial welfare of India." The Institute has over 42 academic departments and centres that come under six divisions.
In 2018, IISc was selected as an Institution of Eminence (IoE) by the Government of India, and it consistently figures among the top Indian institutions in world university rankings.
Also read- Bharat Serums And Vaccines, IISc Ink Pact To Develop Next-Generation Snakebite Therapy In India
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.